Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp198 | Thyroid 1 | ECE2017

Which is the best tool to use when initiating the differential diagnosis of a thyrotoxic patient? A challenge to current guideline recommendations

Perdomo Carolina , Ramos Elisa Gil , Buey Gala Gutierrez , Llavero Maria , Gargallo Javier , Arbizu Javier , de la Higuera Magdalena , Galofre Juan C

Aim: Differential diagnosis (DD) of thyrotoxicosis is critical as the treatment of the three main causes of this condition (Graves’ disease [GD], Toxic Multinodular Goitre [TMG], and Thyroiditis [TS]) differs substantially. Recently published diagnostic algorithms investigating hyperthyroidism embrace the presence of thyrotropin receptor (TSH-R) antibodies (TRab) as the first and most cruicial diagnostic step. Although TRab measurement has important limitations (some can ...

ea0049ep76 | Adrenal cortex (to include Cushing's) | ECE2017

Clinical course of patients with adrenal incidentaloma: retrospective analysis of a single center

Serrano Ana Carolina Ruiz , Colet Ana Megia , Cortes Silvia Naf , Ortega Joan Vendrell , Muela Inmaculada Simon , Fraile Esther Solano , Alevras Theodora Michalopoulou

In the adrenal incidentaloma (AI) it is fundamental to determine functionality and benignity. The aim of this study was to evaluated the clinical, radiological and hormonal evolution of AI and compare the frequency of autonomous cortisol secretion (ACS) between American and European Guidelines.Methods: Retrospective evaluation of patients with AI referred to our service in the last 5 years.Results: 140 patients were included, 50.9%...

ea0049ep227 | Bone & Osteoporosis | ECE2017

Bone remodeling markers predict bone loss in premenopausal women

Buey Gala Gutierrez , Botella Sonsoles , Restituto Patricia , Fraile Macarena Rodriguez , Calleja Amparo , Llavero Maria , Gargallo Javier , Perdomo Carolina , Andrada Patricia , Varo Nerea , Galofre Juan C

Aim: Bone turnover markers (BTMs) predict more rapid rates of bone loss. However, most of these studies have been carried out in postmenopausal women. Few prospective studies have examined the degradation marker C-terminal telopeptide of type I collagen (CTX) and the bone formation marker N-aminoterminal propeptide of type I collagen (P1NP) measured during the menopausal transition to predict the subsequent bone loss.Methods: We performed a prospective c...

ea0049ep456 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Response to stroke in diabetic versus non-diabetic patients. Should Diabetes education systematically include advise on stroke symptoms and the correct response to them?

Gonzalez-Lazaro Paloma , Silva-Fernandez Julia , Garcia-Ruiz Rafael , Garcia-Ruiz Rosa , Gomez-Alfonso Francisco Javier , Del Val-Zaballos Florentino , Torres-Arroyo Belvis , Gonzalez-Pereira Carolina

Introduction: Stroke is the second cause of death in the world and the first cause of disability. It is also the second cause of Diabetes-related death. The success of reperfusion therapies is time-dependent, with most delays being patient-related. We investigated the response to stroke in diabetic patients (DM), as their risk of stroke is increased by 1,8-6 times.Material and Methods: Consecutive patients with acute stroke or transient ischemic attack w...

ea0049ep899 | Neuroendocrinology | ECE2017

Endogenous Cushing’s syndrome ( clinical and biochemical features in a large cohort of patients

Vilar Lucio , Vilar Clarice , Albuquerque Jose Luciano , Trovao Erik , The Ana Carolina , Gadelha Patricia , Melo Maira , Gomes Barbara , Borges Thaise , Cardoso Izabela , Lyra Ruy

Patients and methods: We retrospectively analysed the clinical and biochemical characteristics of a cohort of 150 patients with endogenous Cushing’s syndrome (CS). Cushing’s disease (CD) accounted for 61.3% of cases (n=92), ectopic ACTH secretion (EAS) 7.3% (n=11), and adrenal diseases 31.3% (n=47). Among CD cases, there were 19 macroadenomas (20.6%), a female predominance (60.5%) and a median age of 33 years old (range 14–55). Bronchi...

ea0049ep1446 | Thyroid (non-cancer) | ECE2017

Medullary thyroid carcinoma – diagnosis and outcome of patients treated in a tertiary center

Prokop Joanna , Palha Ana , Sabino Teresa , Neves Carolina , Cortez Luisa , Silva-Nunes Jose , Santos Cristina , Matos Lurdes , Candeias Natercia , Afonso Antonio , Fonseca Fernando , Agapito Ana

Medullary thyroid carcinoma (MTC) is a rare tumor of C cell origin, that may be sporadic or familial. Diagnosis is often delayed and its course variable.Objectives: Evaluation of clinical characteristics and outcome of patients diagnosed with MTC.Methods: Retrospective analysis of clinical records of patients with MTC between 2005 and 2016. We considered undetectable serum calcitonin as criteria of cure.Resul...

ea0041ep31 | Adrenal cortex (to include Cushing's) | ECE2016

Primary aldosteronism – results from the first Portuguese multicentre study

Nunes da Silva Tiago , Fernandes Vera , Martins Diana , Goncalves Diana , Almeida Raquel , Margarida Monteiro Ana , Neves Carolina , Simoes Helder , Marques Pedro , Alves Filipa , Pereira Maria

Primary Aldosteronism (PA) is the most prevalent cause of secondary hypertension. The aim of this work was to characterize the diagnostic workup, treatment and follow-up of confirmed PA.The adrenal tumour study group of the Portuguese Society of Endocrinology undertook the first retrospective multicentre study of Portuguese PA patients. Data was gathered from nine Portuguese Endocrinology centres (three in the north, one in the centre and five in the sou...

ea0041ep60 | Adrenal cortex (to include Cushing's) | ECE2016

Primary hyperaldosteronism: clinical and therapeutic approach of a center

Martins Diana , Moreno Carolina , Baptista Carla , Paiva Isabel , Guelho Daniela , Vicente Nuno , Cardoso Luis , Oliveira Diana , Lages Adriana , Ventura Mara , Carrilho Francisco

Introduction: Primary hyperaldosteronism (HAP) is the main cause of secondary hypertension, with a prevalence estimated between 6 and 20% in resistant hypertension. Clinical suspicion is critical, especially if aldosterone-to-renin ratio (ARR) >25, however the diagnosis is dependent on confirmatory evidence, including aldosterone suppression tests.Methods: Retrospective evaluation of 44 patients with suspected PAH, identified betwee...

ea0041ep338 | Clinical case reports - Thyroid/Others | ECE2016

Diabetes mellitus and ataxia with anti-glutamic acid decarboxylase antibodies

Oliveira Diana , Araujo Rui , Moreno Carolina , Rodrigues Dircea , Guelho Daniela , Vicente Nuno , Cardoso Luis , Martins Diana , Lages Adriana , Ventura Mara , Paiva Sandra , Carrilho Francisco

Introduction: Glutamic acid decarboxylase (GAD65) is expressed by pancreatic beta cells and also by GABA (gamma-aminobutyric acid)-secreting neurons. Cerebellar ataxia associated with anti-GAD65 antibodies (antiGAD Ab) is a rare neurological disorder that frequently coexists with other autoimmune conditions, namely Diabetes Mellitus (DM).Case reports: We describe two cases of ataxia associated with antiGAD Ab. The first case is a 69-year-old obe...

ea0040p21 | (1) | ESEBEC2016

Pituicytoma: a rare tumor

Oliveira Diana , Gomes Leonor , Rodrigues Dircea , Belo Francisco , Rebelo Olinda , Paiva Sandra , Moreno Carolina , Guelho Daniela , Balsa Ana Margarida , Rodrigues Nuno , Cardoso Luis , Martins Diana , Carrilho Francisco

Introduction: Pituicytoma is a low-grade glioma of the suprasellar and sellar regions that is rarely described (about 60 cases described in the literature). The clinical, laboratory and neuroradiological findings are not pathognomonic, and therefore definitive diagnosis is only possible after surgery and histopathological study. Total resection is the treatment of choice, since subtotal removal can often lead to recurrence or progression.Case report: We ...